ReviewLung2021
Pulmonary Pathology Diagnoses in the US Military During the Global War on Terrorism.
Review in Lung, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 9 citations in OpenAlex.
- Particle analysis of surgical lung biopsies from deployed and non-deployed US service members during the Global War on Terrorism.PloS one · 2024Article
- Article
- Histopathologic Insights into Distal Lung Injury and Inflammation following Military Deployment.American journal of respiratory and critical care medicine · 2022Article
- LUNG Year in Review: 2021.Lung · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo document and compare prevalences of pulmonary pathology diagnoses among US Service members deployed during the Global War on Terrorism and non-deployed US service members. Difficulties establishing associations between deployment-related exposures and pulmonary pathology reported among US military service members deployed during the Global War on Terrorism include retrospective estimations of exposures, documenting medical outcomes and lack of comparison groups.
methodsPulmonary diagnoses reported between 2002 and 2015 were identified from the records of the former Armed Forces Institute of Pathology and The Joint Pathology Center. Military service and deployment were confirmed by the Defense Manpower Data Center. Diagnoses were reviewed and coded due to variations in diagnostic terminology. Propensity matching and adjusted binomial modeling were applied to comparisons between the deployed and non-deployed to address possible confounding variables.
results404 deployed and 2006 non-deployed service members were included. Demographic differences and the date of pathology report complicate unadjusted comparisons. The deployed had no significant increased prevalence of neoplastic conditions. Propensity matching identified a significant increased prevalence of organizing pneumonia in the non-deployed. An adjusted binomial model identified significant increased prevalences of small airways disease, constrictive bronchiolitis and hypersensitivity pneumonitis in the deployed. Both diagnoses were strongly associated with the date of pathology report. Small airways disease, constrictive bronchiolitis comprised 5% of deployed surgical lung biopsy diagnoses.
conclusionThis is the largest study of post-deployment pulmonary pathology diagnoses to date, and contains a comparison group. It provides context for studies of pulmonary outcomes among the deployed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.